80,000
Participants
Start Date
September 30, 1983
Study Completion Date
December 31, 2004
Hep-V Vax
Qidong Liver Cancer Institute, Qidong
Cancer Institute, Chinese Academy of Medical Sciences, Beijing
Clinical Trial Service Unit and Epidemiological Studies Unit, Oxford
Collaborators (1)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
OTHER
Qidong Liver Cancer Institute
OTHER
Merck Institute for Therapeutic Research
UNKNOWN
University of Oxford
OTHER